PPT-Overview of the African Medicines Regulatory

Author : celsa-spraggs | Published Date : 2018-11-21

Harmonization and African Medicines Agency Margareth NdomondoSigonda NEPAD Planning and Coordinating Agency Midrand Johannesburg South Africa OUTLINE Introduction

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Overview of the African Medicines Regu..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Overview of the African Medicines Regulatory: Transcript

Harmonization and African Medicines Agency Margareth NdomondoSigonda NEPAD Planning and Coordinating Agency Midrand Johannesburg South Africa OUTLINE Introduction to NEPAD Background and Overview of the African . The majority of international regulatory authorities are obliged by law to have systems in place to verify As an initial effort to improve international sharing of information and to facilitate more Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. Programme. General overview and . update. Dr Milan . Smid. WHO Prequalification of Medicines Programme. Amman, June 2013. UN Prequalification . Programme. . for Priority Essential Medicines. Action plan of UN from 2001 for expanding access to selected priority medicines . products. Milan . Smid. . Prequalification team . Principal objective of PQP capacity building: . To facilitate availability of quality priority medicines. Good quality submissions and compliance with "good practices". Capacity Building and Harmonization Support. Regulatory . Systems Strengthening [RSS]. Regulation of Medicines and Other Health Technologies [RHT]. Department of Essential Medicines and Health Products [EMP]. By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. to 17 December 2014 . World Bank, Washington DC. Quality and Regulatory Agenda. NRA. * . joint . assessment . tool: progress for consultation amongst partners . Lahouari Belgharbi, Scientist, WHO/HQ . Ms. Leah Goodman. Contents. Key Messages. An Overview - Biological Medicines and their Regulatory Framework. PhAMA Position and Recommendation on Biosimilars . An Overview - Biological Medicines and their Regulatory Framework. DR DORCAS PETA. 1 JUNE 2012. ACKNOWLEDGEMENT. This presentation is a summary of presentations delivered at ARC by the various speakers. It is intended to provide feedback to SAPRAA members who were unable to attend the conference. . Capacity Building and Harmonization Support. Regulatory . Systems Strengthening [RSS]. Regulation of Medicines and Other Health Technologies [RHT]. Department of Essential Medicines and Health Products [EMP]. ealtEMA Regulatory Science to 2025Strategic rex0066006CectionContentsForeword by Prof Guido Rasi EMA Executive Director1Vision 151 Human medicines2Vision 151 Veterinary medicines41 Introduction 151 th UKMi Horizon Scanning Working Group. Jim Glare. West Midlands Medicines Information Service. 11-Nov-2018. Objectives. This presentation aims to give some understanding of:. the ‘life-cycle’ of a medicine. Inês Reis – Statistical assessor MHRA. PSI Career Young Statistician Webinar Session – 9 June 2020. Disclaimer. The views expressed in this presentation are my own and should not be understood or quoted as being made on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) or any other entity..

Download Document

Here is the link to download the presentation.
"Overview of the African Medicines Regulatory"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.